证券记录 · 已归档季度
WST
West Pharmaceutical Services, Inc. · Healthcare · Medical - Instruments & Supplies
13被追踪持有人
—Δ持有人
5.33M持有股份
$1.75B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +3 | 50.44M | $18.07B | +8 | −4 |
| Q1 2026 | 161 | -2 | 49.75M | $12.46B | +4 | −7 |
| Q4 2025 | 162 | +3 | 53.70M | $14.74B | +5 | −1 |
| Q3 2025 | 21 | -1 | 26.99M | $7.08B | — | −2 |
| Q2 2025 | 20 | 0 | 24.84M | $5.43B | +1 | −1 |
| Q1 2025 | 17 | +2 | 8.37M | $1.87B | +2 | — |
| Q4 2024 | 15 | +2 | 8.55M | $2.80B | +2 | — |
| Q3 2024 | 12 | -1 | 4.43M | $1.33B | — | −1 |
| Q2 2024 | 13 | — | 5.33M | $1.75B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 1.73M | — | $567.45M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 1.73M | — | $567.45M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.69M | — | $557.93M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.69M | — | $557.93M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (被动) | 866.37K | — | $285.37M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 393.86K | — | $129.73M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 280.34K | — | $92.34M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 280.34K | — | $92.34M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 169.91K | — | $55.97M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 82.38K | — | $27.14M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 47.98K | — | $15.80M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Marshall Wace ✦ | 47.98K | — | $15.80M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 28.77K | — | $9.48M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 17.55K | — | $5.78M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 17.55K | — | $5.78M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 15.24K | — | $5.02M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 15.24K | — | $5.02M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 5.76K | — | $1.90M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 5.76K | — | $1.90M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 5.76K | — | $1.90M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 2.11K | — | $694,684 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 749 持有人, 70.07M 股份, $16.37B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 06
SC 13G — FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据